These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33650607)

  • 1. Molecular self-assembly of a tyroservatide-derived octapeptide and hydroxycamptothecin for enhanced therapeutic efficacy.
    Liu J; Wu C; Dai G; Feng F; Chi Y; Xu K; Zhong W
    Nanoscale; 2021 Mar; 13(9):5094-5102. PubMed ID: 33650607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic Synthesis of Peptide Nanofibers for Self-Delivery of Indomethacin and Tyroservatide in Cancer Therapy.
    Wang C; Zheng Y; Zheng Y; Wu C; Wang X; Huang M; Wu X; Zhong W; Xu K
    ACS Biomater Sci Eng; 2022 Jul; 8(7):3010-3021. PubMed ID: 35679601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer Supramolecular Hydrogel of D/L-Peptide with Enhanced Stability and Bioactivity.
    Ren C; Gao Y; Liu J; Zhang Y; Pu G; Yang L; Huang F; Yang C; Yang Z; Liu J
    J Biomed Nanotechnol; 2018 Jun; 14(6):1125-1134. PubMed ID: 29843877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyroservatide therapy for tumor growth, invasion and metastasis of Lewis lung carcinoma and human lung carcinoma A549.
    Zheng M; Lu R; Che X; Li J; Zhou C; Wang L; Xu Q; Cao H; Li Q; Yao Z
    Oncology; 2006; 70(6):418-26. PubMed ID: 17245103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supramolecular Hydrogel Based on Chlorambucil and Peptide Drug for Cancer Combination Therapy.
    Yang L; Zhang C; Ren C; Liu J; Zhang Y; Wang J; Huang F; Zhang L; Liu J
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):331-339. PubMed ID: 30560665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment.
    Jin X; Li M; Yin L; Zhou J; Zhang Z; Lv H
    Nanomedicine; 2017 Apr; 13(3):1105-1115. PubMed ID: 27845234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP.
    Guo Q; Liu Y; Wang Z; Zhang J; Mu G; Wang W; Liu J
    Acta Biomater; 2021 Mar; 122():343-353. PubMed ID: 33444804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
    Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
    Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-Free Supramolecular Hydrogel Composed of Dual Drugs for Conquering Drug Resistance.
    Ren C; Gao Y; Guan Y; Wang Z; Yang L; Gao J; Fan H; Liu J
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33706-33715. PubMed ID: 31466443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembling peptide of D-amino acids boosts selectivity and antitumor efficacy of 10-hydroxycamptothecin.
    Liu J; Liu J; Chu L; Zhang Y; Xu H; Kong D; Yang Z; Yang C; Ding D
    ACS Appl Mater Interfaces; 2014 Apr; 6(8):5558-65. PubMed ID: 24660962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of tyroservatide on metastasis of lung cancer and its mechanism affecting integrin-focal adhesion kinase signal transduction.
    Huang YT; Zhao L; Fu Z; Zhao M; Song XM; Jia J; Wang S; Li JP; Zhu ZF; Lin G; Lu R; Yao Z
    Drug Des Devel Ther; 2016; 10():649-63. PubMed ID: 27041993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-responsive supramolecular hydrogel based on 10-hydroxy camptothecin-peptide covalent conjugates with high loading capacity for drug delivery.
    Wu C; Li R; Yin Y; Wang J; Zhang L; Zhong W
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():196-202. PubMed ID: 28482517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of 10-hydroxy camptothecin in supramolecular hydrogel as an injectable drug delivery system.
    Li R; Shu C; Wang W; Wang X; Li H; Xu D; Zhong W
    J Pharm Sci; 2015 Jul; 104(7):2266-75. PubMed ID: 25980666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
    Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
    Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
    Zhang X; Gan Y; Gan L; Nie S; Pan W
    J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Supramolecular Drug-Drug Delivery System for Non-Small-Cell Lung Cancer Therapy.
    Zhang Z; Shi L; Wu C; Su Y; Qian J; Deng H; Zhu X
    ACS Appl Mater Interfaces; 2017 Sep; 9(35):29505-29514. PubMed ID: 28809468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-free, self-assembled pure drug nanorods composed of 10-hydroxycamptothecin and chlorin e6 for combinatorial chemo-photodynamic antitumor therapy in vivo.
    Wen Y; Zhang W; Gong N; Wang YF; Guo HB; Guo W; Wang PC; Liang XJ
    Nanoscale; 2017 Oct; 9(38):14347-14356. PubMed ID: 28731112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy.
    Fu S; Li G; Zang W; Zhou X; Shi K; Zhai Y
    Acta Pharm Sin B; 2022 Jan; 12(1):92-106. PubMed ID: 35127374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tyroservatide on histone acetylation in lung carcinoma cells.
    Xu Q; Lu R; Zhu ZF; Lv JQ; Wang LJ; Zhang W; Hu JW; Meng J; Lin G; Yao Z
    Int J Cancer; 2011 Jan; 128(2):460-72. PubMed ID: 20309941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
    Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G
    Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.